ESMO/LinkedIn
May 18, 2025, 07:46
What are the key benefits of the ESMO-MCBS – ESMO
European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“Since 2015, the ESMO-Magnitude of Clinical Scale (ESMO-MCBS) has provided a standardised way to assess the value of cancer treatments based on their clinical benefit — supporting decisions in Daily Practice, research, and Public Health.
With the oncology landscape evolving rapidly, ESMO has been working to ensure the scale remains relevant and useful for clinicians, researchers and policymakers — revising it regularly to respond to changes in Clinical Evidence and regulatory requirements.
An important evolution is just around the corner — keep an eye out.”
More posts feauturing ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 13:03
Jul 27, 2025, 07:35
Jul 27, 2025, 06:56
Jul 27, 2025, 06:39
Jul 27, 2025, 06:30
Jul 27, 2025, 06:13
Jul 27, 2025, 06:10
Jul 27, 2025, 06:08